Association of Sat-a and Alu methylation status with HCV-induced chronic liver disease and hepatocellular carcinoma

Bibliographic Information
Authors: El-Ahwany E.; Hassan M.; Elzallat M.; Abdelsalam L.; El-Sawy M.A.-H.; Seyam M.
Journal: Virus Research
Publisher: Elsevier B.V.
Publication Date: November 2022
Volume / Issue: Volume 321
Article No.: 198928
ISSN: 1681702
DOI: 10.1016/j.virusres.2022.198928
Scopus: View on Scopus
PubMed: 36100006
Document Type: Article
Authors and Affiliations
El-Ahwany E., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Hassan M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Abdelsalam L., Human Genetics Department, Faculty of Medicine, Cairo University, Cairo, Egypt, Human Genetics Department, Faculty of Medicine, University of North Carolina, United States; El-Sawy M.A.-H., Hepato-Gastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt; Seyam M., Hepato-Gastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Background: The combination of epigenetic and genetic abnormalities contributes together to the development of liver cancer. The methylation status of the repetitive elements (REs) in DNA has been investigated in a variety of human illnesses. However, the methylation patterns of Sat-α and Alu REs in chronic liver disease (CLD) and hepatocellular carcinoma (HCC) caused by hepatitis C virus (HCV) have never been studied before. Methodology: In this study, 3 groups of participants including 50 patients having HCV-induced CLD, 50 patients having HCV-induced HCC, and 46 healthy subjects were subjected to measurement of Sat-α and Alu methylation using the quantitative MethyLight assay. Results: Sat-α and Alu methylation percentages decreased significantly in both CLD and HCC, compared to control. Also, a significant Sat-α hypomethylation was detected in HCC, compared to CLD. In addition, Sat-α and Alu methylation showed a significant decline as lesion size grew. However, only Sat-α hypomethylation was significantly increased in association with portal vein thrombosis and the MELD score. Sat-α methylation percentage had the highest sensitivity and specificity for diagnosing HCC (100% and 84.4%) followed by α-fetoprotein (80% and 84.4%) and Alu methylation (66% and 61.5%). Furthermore, there was a strong positive correlation between Sat-α and Alu methylation. Conclusions: Measuring Sat-α and Alu methylation provides us with a new tool for early detecting HCV-induced CLD and hepatocarcinogenesis. Sat-α has the potential to be utilized as an independent predictive parameter for HCC development and progression because of its ability to distinguish between CLD and HCC with their different MELD scores. © 2022
Keywords
Alu; Chronic liver disease; DNA methylation; Hepatitis C virus; Hepatocellular carcinoma; Sat-α; alpha-Fetoproteins; Carcinoma, Hepatocellular; DNA; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; alanine aminotransferase; albumin; alpha fetoprotein; aspartate aminotransferase; bilirubin; adult; age; aged; alpha satellite repetitive elements; Alu repeat; Article; biochemical analysis; cancer staging; Child Pugh score; clinical article; correlational study; demographics; DNA structure; female; gender; human; international normalized ratio; liver cell carcinoma; male; Model For End Stage Liver Disease Score; platelet count; portal vein thrombosis; radiological parameters; sensitivity and specificity; virus pathogenesis; genetics; liver tumor
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
